Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes
Vitamin B6 metabolism,3/6,0.0022241766503380937,0.6850464083041329,0,0,10,61.08368476639271,PHOSPHO2;PSAT1;AOX1
Drug metabolism,12/108,0.007714400432695527,1,0,0,2.222222222222222,10.8103700237306,ALDH3A1;CYP2B6;UCK1;GSTA3;UGT2B15;GSTA1;AOX1;FMO1;NME4;UGT1A3;CYP2C19;NME1
Cholesterol metabolism,7/50,0.011679559996652222,1,0,0,2.8000000000000003,12.459761926671213,ABCA1;OSBPL5;APOH;ANGPTL8;LCAT;APOA4;CD36
Hippo signaling pathway,15/160,0.014391384367797242,1,0,0,1.875,7.952110423592947,WWTR1;CRB1;WNT5B;SOX2;MOB1B;LATS1;LATS2;PPP2R1B;PPP2R2B;ID2;ID1;PPP2R2D;SNAI2;AJUBA;TP73
Chemical carcinogenesis,8/82,0.05220786888704381,1,0,0,1.951219512195122,5.7610186351061445,ALDH3A1;GSTA3;UGT2B15;GSTA1;KYAT3;UGT1A3;CYP2C19;SULT1A2
Citrate cycle (TCA cycle),4/30,0.06063113352204076,1,0,0,2.6666666666666665,7.474524702251736,PC;IDH3G;ACO2;PCK1
Glyoxylate and dicarboxylate metabolism,4/30,0.06063113352204076,1,0,0,2.6666666666666665,7.474524702251736,GCSH;HYI;ACO2;ACSS1
Circadian rhythm,4/31,0.06697579978121662,1,0,0,2.5806451612903225,6.976577863571356,BHLHE41;RORA;NR1D1;NPAS2
Glucagon signaling pathway,9/103,0.07261232571253211,1,0,0,1.7475728155339805,4.583220458866479,PPP4C;PRMT1;PDE3B;EP300;ITPR2;PPP4R3A;PCK1;FOXO1;GCK
Metabolism of xenobiotics by cytochrome P450,7/74,0.07622483813171252,1,0,0,1.8918918918918919,4.869858207482098,ALDH3A1;CYP2B6;GSTA3;CYP2S1;UGT2B15;GSTA1;UGT1A3
"Valine, leucine and isoleucine degradation",5/48,0.0904238200779985,1,0,0,2.0833333333333335,5.006765728864707,AGXT2;IVD;AOX1;HSD17B10;BCAT2
JAK-STAT signaling pathway,12/162,0.11279258616386696,1,0,0,1.4814814814814814,3.23289580381604,IL6;EPO;IL23A;IL2RB;IFNK;OSM;EP300;AOX1;PIAS2;IRF9;IFNA10;CRLF2
Long-term potentiation,6/67,0.11758211344423333,1,0,0,1.7910447761194028,3.8339433163846697,GRIA2;GRM5;RPS6KA1;EP300;ITPR2;GRIN2B
Protein processing in endoplasmic reticulum,12/165,0.12430307174535642,1,0,0,1.4545454545454544,3.0327746449727915,ERN1;PRKN;HSPA8;HSP90AB1;SAR1B;WFS1;UBE2D2;EDEM2;ATF6;SEC31B;CKAP4;DDOST
Ferroptosis,4/40,0.1379595947094308,1,0,0,2,3.961588857315027,TF;LPCAT3;SAT1;SLC39A14
Folate biosynthesis,3/26,0.1385193121264188,1,0,0,2.3076923076923075,4.561720443090936,MOCOS;AKR1C3;GPHN
Maturity onset diabetes of the young,3/26,0.1385193121264188,1,0,0,2.3076923076923075,4.561720443090936,NR5A2;GCK;NKX2-2
Legionellosis,5/55,0.13937991022954382,1,0,0,1.8181818181818181,3.582821649166955,NFKBIA;HSPA8;IL6;SAR1B;CD14
Chagas disease (American trypanosomiasis),8/103,0.1436496829254225,1,0,0,1.553398058252427,3.0141789527471206,NFKBIA;IKBKB;C1QB;GNA14;IL6;PPP2R1B;PPP2R2B;PPP2R2D
Fat digestion and absorption,4/41,0.14721479282726987,1,0,0,1.951219512195122,3.7382684546071134,ABCA1;APOA4;CD36;AGPAT2
Alzheimer disease,12/171,0.14921456820265613,1,0,0,1.4035087719298245,2.6699929177125634,ERN1;PSENEN;RTN3;NDUFA6;ATP5PB;ATP5MC3;ITPR2;COX6A1;ATP5F1C;ATF6;GRIN2B;HSD17B10
C-type lectin receptor signaling pathway,8/104,0.14927432324369838,1,0,0,1.5384615384615385,2.9261070310469814,NFKBIA;IKBKB;IL6;IL23A;BCL3;ITPR2;MAP3K14;IRF9
Chemokine signaling pathway,13/190,0.1570723918012497,1,0,0,1.368421052631579,2.533013717177419,CXCL9;PXN;CXCR6;PIK3R6;CXCL5;NFKBIA;IKBKB;GNB3;RAC3;CCR6;CCL27;CCR2;CCL26
PPAR signaling pathway,6/74,0.1647057705275506,1,0,0,1.6216216216216217,2.924748009429989,ACOX1;CD36;PLIN1;PCK1;ACSBG2;PPARD
Thiamine metabolism,2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,AK2;AK8
Insulin resistance,8/108,0.17280406327587397,1,0,0,1.4814814814814814,2.6008843089787628,NFKBIA;IKBKB;IL6;PPP1R3B;RPS6KA1;CD36;PCK1;FOXO1
Pertussis,6/76,0.17945756311992533,1,0,0,1.5789473684210524,2.712341867627267,C4B;C1QB;IL6;IL23A;CD14;CXCL5
IL-17 signaling pathway,7/93,0.18346339954975327,1,0,0,1.5053763440860215,2.552727015512764,IKBKB;NFKBIA;IL6;HSP90AB1;SRSF1;DEFB4B;CXCL5
TNF signaling pathway,8/110,0.18515647013830153,1,0,0,1.4545454545454544,2.453169493595112,RPS6KA4;NFKBIA;IKBKB;IL6;MLKL;BCL3;MAP3K14;CXCL5
Basal transcription factors,4/45,0.18643368284604128,1,0,0,1.7777777777777777,2.98609722860718,GTF2A1L;TBPL1;TAF9B;TAF2
Purine metabolism,9/129,0.19716308132492769,1,0,0,1.3953488372093021,2.265661491233072,GUCY2C;ENTPD3;PDE3B;AK2;PDE6D;NME4;PDE8B;AK8;NME1
Mucin type O-glycan biosynthesis,3/31,0.20065196718317338,1,0,0,1.9354838709677418,3.1087420224475646,GALNT15;B3GNT6;GCNT4
Cytosolic DNA-sensing pathway,5/63,0.20636211070548938,1,0,0,1.5873015873015872,2.504956879983314,IKBKB;NFKBIA;IL6;IFNA10;POLR2L
Cysteine and methionine metabolism,4/47,0.20718336704116536,1,0,0,1.7021276595744679,2.679406036964871,AGXT2;KYAT3;MAT2B;BCAT2
Sphingolipid metabolism,4/47,0.20718336704116536,1,0,0,1.7021276595744679,2.679406036964871,UGCG;NEU4;NEU1;SGMS2
Cytokine-cytokine receptor interaction,18/294,0.2199667352453474,1,0,0,1.2244897959183672,1.8542191193784556,ACVRL1;CXCL9;TNFSF15;EPO;OSM;TNFRSF10B;CXCR6;CXCL5;IL6;IL23A;IL2RB;IFNK;CCR6;CCL27;CCR2;CCL26;CRLF2;IFNA10
"Neomycin, kanamycin and gentamicin biosynthesis",1/5,0.22623900494711593,1,0,0,4,5.9446531780071785,GCK
Other glycan degradation,2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,NEU4;NEU1
Peroxisome,6/83,0.23481354624178025,1,0,0,1.4457831325301203,2.0948869879664898,SLC25A17;ACOX1;MPV17L;ECI2;PXMP4;PEX26
Influenza A,11/171,0.23723836295709655,1,0,0,1.286549707602339,1.8509460603998853,NFKBIA;IKBKB;HSPA8;IL6;NXF2;XPO1;EP300;TNFRSF10B;IRF9;AGFG1;IFNA10
Pentose and glucuronate interconversions,3/34,0.24057000906593404,1,0,0,1.7647058823529411,2.5142543537821203,RPEL1;UGT2B15;UGT1A3
SNARE interactions in vesicular transport,3/34,0.24057000906593404,1,0,0,1.7647058823529411,2.5142543537821203,STX7;BET1L;VAMP3
Retinol metabolism,5/67,0.2431934021901658,1,0,0,1.4925373134328357,2.1102959080752326,CYP2B6;CYP2S1;UGT2B15;AOX1;UGT1A3
Pantothenate and CoA biosynthesis,2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,PANK2;BCAT2
Insulin signaling pathway,9/137,0.2472046870434335,1,0,0,1.313868613138686,1.8361820930540071,IKBKB;PPP1R3B;PRKAR2A;PDE3B;FLOT1;TRIP10;PCK1;FOXO1;GCK
AMPK signaling pathway,8/120,0.2519691354453672,1,0,0,1.3333333333333333,1.8379315698176057,PFKFB3;PPP2R1B;PPP2R2B;STRADB;PPP2R2D;CD36;PCK1;FOXO1
Epithelial cell signaling in Helicobacter pylori infection,5/68,0.25266492029805,1,0,0,1.4705882352941175,2.023075137913094,IKBKB;NFKBIA;MET;ATP6V0D2;MAP3K14
Staphylococcus aureus infection,5/68,0.25266492029805,1,0,0,1.4705882352941175,2.023075137913094,C4B;C1QB;DEFA4;DEFB4B;MBL2
Adipocytokine signaling pathway,5/69,0.26222604197239524,1,0,0,1.4492753623188406,1.9399252051607478,IKBKB;NFKBIA;CD36;PCK1;ACSBG2
DNA replication,3/36,0.2678594070249647,1,0,0,1.6666666666666665,2.1954883946257717,PCNA;MCM3;MCM4
Th17 cell differentiation,7/107,0.28762785288726417,1,0,0,1.3084112149532707,1.6303952679093834,NFKBIA;IKBKB;IL6;HSP90AB1;IL23A;IL2RB;RORA
Adherens junction,5/72,0.2913681345785638,1,0,0,1.3888888888888888,1.712732977852415,EP300;RAC3;SNAI2;MET;NECTIN3
p53 signaling pathway,5/72,0.2913681345785638,1,0,0,1.3888888888888888,1.712732977852415,CCNG2;CCNG1;TNFRSF10B;GTSE1;TP73
Pyruvate metabolism,3/39,0.3093526636827237,1,0,0,1.5384615384615385,1.8050359176351607,PC;ACSS1;PCK1
Pyrimidine metabolism,4/57,0.31821716196314576,1,0,0,1.4035087719298245,1.6070473403738648,UCK1;ENTPD3;NME4;NME1
Mismatch repair,2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,MSH6;PCNA
"Glycine, serine and threonine metabolism",3/40,0.3232493972692518,1,0,0,1.4999999999999998,1.693996688892286,GCSH;AGXT2;PSAT1
Nicotine addiction,3/40,0.3232493972692518,1,0,0,1.4999999999999998,1.693996688892286,GABRB3;GRIA2;GRIN2B
Herpes simplex virus 1 infection,27/492,0.3361646511754941,1,0,0,1.097560975609756,1.1965107136671458,ZNF793;ZNF132;ZNF273;SRSF1;ZNF3;ZNF7;IKBKB;ZNF829;NXF2;ZNF607;ZNF429;ZSCAN32;ZNF107;ZNF567;ZNF600;ZNF224;ZNF223;ZNF641;ZNF200;CD74;ZNF284;NFKBIA;IL6;ZNF74;ZNF311;IRF9;IFNA10
Sulfur relay system,1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CTU2
Vitamin digestion and absorption,2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,CUBN;APOA4
FoxO signaling pathway,8/132,0.3401270250872685,1,0,0,1.2121212121212122,1.307195306601671,IKBKB;IL6;PRMT1;FOXG1;CCNG2;EP300;PCK1;FOXO1
Steroid hormone biosynthesis,4/60,0.3527005497730227,1,0,0,1.3333333333333333,1.3895145106479536,DHRS11;UGT2B15;AKR1C3;UGT1A3
Spliceosome,8/134,0.3553149637378668,1,0,0,1.1940298507462686,1.23552317738332,ISY1;TCERG1;HSPA8;PRPF38B;SNRPD2;TRA2B;SRSF1;SNU13
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,PIGC;PIGW
Complement and coagulation cascades,5/79,0.36105764852361333,1,0,0,1.2658227848101267,1.2895160027815111,C4B;C1QB;A2M;MBL2;F2RL3
Fatty acid degradation,3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,ACOX1;ECI2;ACSBG2
HIF-1 signaling pathway,6/100,0.38397671632870417,1,0,0,1.2,1.1486080353521109,TF;IL6;PFKFB3;ANGPT1;EPO;EP300
Measles,8/138,0.38588815366024015,1,0,0,1.1594202898550725,1.1040089378109808,NFKBIA;IKBKB;HSPA8;IL6;IL2RB;IRF9;IFNA10;TP73
Ascorbate and aldarate metabolism,2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,UGT2B15;UGT1A3
Biosynthesis of unsaturated fatty acids,2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,ELOVL4;ACOX1
Collecting duct acid secretion,2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,SLC4A1;ATP6V0D2
NOD-like receptor signaling pathway,10/178,0.3989542659955018,1,0,0,1.1235955056179774,1.032481449693242,NFKBIA;IKBKB;IL6;HSP90AB1;DEFA4;ITPR2;RBCK1;DEFB4B;IRF9;IFNA10
Lysosome,7/123,0.4184152232009605,1,0,0,1.1382113821138211,0.9917019313802579,AP4M1;CLN3;NEU1;NAGPA;ATP6V0D2;AP3B2;AP1M2
Nucleotide excision repair,3/47,0.4196120451603213,1,0,0,1.276595744680851,1.1086272722292005,PCNA;ERCC5;BIVM-ERCC5
Toll-like receptor signaling pathway,6/104,0.4200266801120024,1,0,0,1.1538461538461537,1.0008888988224178,NFKBIA;IKBKB;IL6;CXCL9;CD14;IFNA10
Viral carcinogenesis,11/201,0.42334810143404067,1,0,0,1.0945273631840795,0.940812491424585,GTF2A1L;NFKBIA;GSN;DNAJA3;HPN;PXN;TBPL1;EP300;HDAC8;ATP6V0D2;IRF9
Notch signaling pathway,3/48,0.43306631871249,1,0,0,1.25,1.0460805021359667,PSENEN;EP300;DLL1
Cell adhesion molecules (CAMs),8/145,0.4395232982954594,1,0,0,1.103448275862069,0.9071057129387737,SPN;SDC4;MPZ;ICAM3;NRCAM;CD226;NECTIN3;MPZL1
Glycolysis / Gluconeogenesis,4/68,0.44400267624141365,1,0,0,1.176470588235294,0.9552055164674429,ALDH3A1;ACSS1;PCK1;GCK
Arginine and proline metabolism,3/49,0.44640402063272916,1,0,0,1.2244897959183672,0.987588809585937,CKM;P4HA3;SAT1
Malaria,3/49,0.44640402063272916,1,0,0,1.2244897959183672,0.987588809585937,IL6;CD36;MET
Pentose phosphate pathway,2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,RPEL1;DERA
Kaposi sarcoma-associated herpesvirus infection,10/186,0.453202580319,1,0,0,1.075268817204301,0.8509850067631957,NFKBIA;IKBKB;IL6;EP300;ITPR2;GNB3;PIK3R6;IRF9;MICA;IFNA10
Galactose metabolism,2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,LALBA;GCK
RNA polymerase,2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,POLR1E;POLR2L
RIG-I-like receptor signaling pathway,4/70,0.4662992293725246,1,0,0,1.1428571428571428,0.8719174032140833,IKBKB;NFKBIA;IFNK;IFNA10
Rheumatoid arthritis,5/91,0.48023571472567267,1,0,0,1.0989010989010988,0.8060200255732013,IL6;ANGPT1;IL23A;ATP6V0D2;CXCL5
mRNA surveillance pathway,5/91,0.48023571472567267,1,0,0,1.0989010989010988,0.8060200255732013,NXF2;PPP2R1B;PPP2R2B;PPP2R2D;PABPC1
Dopaminergic synapse,7/131,0.4838055078602633,1,0,0,1.0687022900763359,0.7759551258061761,GRIA2;PPP2R1B;PPP2R2B;PPP2R2D;ITPR2;GNB3;GRIN2B
Natural killer cell mediated cytotoxicity,7/131,0.4838055078602633,1,0,0,1.0687022900763359,0.7759551258061761,NCR2;PRF1;TNFRSF10B;RAC3;LCP2;MICA;IFNA10
Human papillomavirus infection,17/330,0.4851528081345037,1,0,0,1.0303030303030303,0.7452092896330131,WNT5B;PXN;TNC;FOXO1;IKBKB;RELN;PPP2R1B;TERT;PPP2R2B;TADA3;PPP2R2D;TBPL1;EP300;ATP6V0D2;IRF9;CRB3;IFNA10
Fatty acid biosynthesis,1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,ACSBG2
Vascular smooth muscle contraction,7/132,0.49185149962456454,1,0,0,1.0606060606060606,0.7525831919041477,KCNU1;PRKCH;PPP1R12A;ADORA2B;ITPR2;KCNMB4;MYH11
Base excision repair,2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,PCNA;APEX1
Oxidative phosphorylation,7/133,0.49985934680088157,1,0,0,1.0526315789473684,0.7299247647707883,NDUFA6;PPA2;ATP5PB;ATP5MC3;COX6A1;ATP5F1C;ATP6V0D2
Huntington disease,10/193,0.5001207874788308,1,0,0,1.0362694300518134,0.7180369272298603,GRM5;NDUFA6;ATP5PB;TBPL1;EP300;ATP5MC3;ATP5F1C;COX6A1;GRIN2B;POLR2L
PI3K-Akt signaling pathway,18/354,0.5053296420630676,1,0,0,1.0169491525423728,0.6941128536601475,HSP90AB1;ANGPT1;EPO;OSM;TNC;PIK3R6;IKBKB;IL6;RELN;PPP2R1B;PPP2R2B;FGF18;PPP2R2D;IL2RB;GNB3;PCK1;MET;IFNA10
Glutamatergic synapse,6/114,0.5083474584006553,1,0,0,1.0526315789473684,0.7122000968180043,GRIA2;GRM5;GRIK3;ITPR2;GNB3;GRIN2B
Inositol phosphate metabolism,4/74,0.5098528753630284,1,0,0,1.0810810810810811,0.7282519724998587,PIP5KL1;ITPKA;OCRL;MTMR6
Regulation of lipolysis in adipocytes,3/55,0.5234350892650081,1,0,0,1.0909090909090908,0.706191545588209,PDE3B;PLIN1;ADRB2
Amoebiasis,5/96,0.5278178232072942,1,0,0,1.0416666666666667,0.6656292568931363,GNA14;IL6;MUC2;CD14;SERPINB6
Prion diseases,2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,C1QB;IL6
Glutathione metabolism,3/56,0.5356989644779965,1,0,0,1.0714285714285714,0.6687674026318335,GSTA3;GSTA1;CHAC1
Glycerophospholipid metabolism,5/97,0.5371052771771576,1,0,0,1.0309278350515463,0.6407846977351693,CHKB;GPAT4;LPCAT3;LCAT;AGPAT2
Hematopoietic cell lineage,5/97,0.5371052771771576,1,0,0,1.0309278350515463,0.6407846977351693,IL6;EPO;CD14;CD36;CD33
Prostate cancer,5/97,0.5371052771771576,1,0,0,1.0309278350515463,0.6407846977351693,NFKBIA;IKBKB;HSP90AB1;EP300;FOXO1
Tyrosine metabolism,2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,ALDH3A1;AOX1
Phosphatidylinositol signaling system,5/99,0.5554224977737025,1,0,0,1.01010101010101,0.5939658561566864,ITPKA;ITPR2;OCRL;MTMR6;IP6K2
RNA degradation,4/79,0.561890006637219,1,0,0,1.0126582278481011,0.5837459908567373,ZCCHC7;PNLDC1;CNOT2;PABPC1
Apoptosis,7/143,0.5772906093016131,1,0,0,0.979020979020979,0.5378834105474285,ERN1;NFKBIA;IKBKB;PRF1;ITPR2;TNFRSF10B;MAP3K14
Nitrogen metabolism,1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,CA7
Phenylalanine metabolism,1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,ALDH3A1
Primary bile acid biosynthesis,1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,CYP46A1
Selenocompound metabolism,1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,KYAT3
Long-term depression,3/60,0.5828910435264506,1,0,0,1,0.5397549994176116,GRIA2;PPP2R1B;ITPR2
Rap1 signaling pathway,10/206,0.583848066481467,1,0,0,0.9708737864077669,0.5224412525591288,APBB1IP;ANGPT1;ADORA2B;ID1;FGF18;RAC3;LCP2;GRIN2B;MET;F2RL3
Platelet activation,6/124,0.5912375561010063,1,0,0,0.9677419354838709,0.5085845672526835,APBB1IP;PPP1R12A;ITPR2;LCP2;PIK3R6;F2RL3
ECM-receptor interaction,4/82,0.591620653904691,1,0,0,0.975609756097561,0.5120874505494942,RELN;SDC4;TNC;CD36
Glycerolipid metabolism,3/61,0.5942021207725078,1,0,0,0.9836065573770492,0.5120023739386589,GPAT4;AGK;AGPAT2
Taste transduction,4/83,0.6012622374752512,1,0,0,0.963855421686747,0.4903364861494962,HTR3D;GNB3;TAS1R2;TAS1R1
Osteoclast differentiation,6/127,0.6146383855730021,1,0,0,0.9448818897637795,0.45989402366767695,NFKBIA;IKBKB;SIRPG;LCP2;MAP3K14;IRF9
Graft-versus-host disease,2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,IL6;PRF1
Arachidonic acid metabolism,3/63,0.6162178817161523,1,0,0,0.9523809523809523,0.4610996894309503,CYP2B6;AKR1C3;CYP2C19
Porphyrin and chlorophyll metabolism,2/42,0.6279256694973029,1,0,0,0.9523809523809523,0.4431747430401906,UGT2B15;UGT1A3
Tryptophan metabolism,2/42,0.6279256694973029,1,0,0,0.9523809523809523,0.4431747430401906,KYAT3;AOX1
Cortisol synthesis and secretion,3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,MRAP;ITPR2;PDE8B
Inflammatory bowel disease (IBD),3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,IL6;IL23A;RORA
Shigellosis,3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,IKBKB;NFKBIA;UBE2D2
Acute myeloid leukemia,3/66,0.6476960862533626,1,0,0,0.9090909090909091,0.3948488139467768,IKBKB;CD14;PPARD
Ribosome,7/153,0.6484975480312875,1,0,0,0.915032679738562,0.3962979599377591,MRPS17;RPSA;RPL15;UBA52;RSL24D1;RPS24;MRPS5
GABAergic synapse,4/89,0.6561310542796738,1,0,0,0.898876404494382,0.3787817816859613,GABRB3;PLCL1;GNB3;GPHN
Hepatitis C,7/155,0.6618579190514627,1,0,0,0.9032258064516128,0.37276523730143096,NFKBIA;IKBKB;PPP2R1B;PPP2R2B;PPP2R2D;IRF9;IFNA10
Salivary secretion,4/90,0.6647641861492688,1,0,0,0.8888888888888888,0.362953696452133,DMBT1;ITPR2;ADRB2;PRH1
TGF-beta signaling pathway,4/90,0.6647641861492688,1,0,0,0.8888888888888888,0.362953696452133,PPP2R1B;ID2;ID1;EP300
ABC transporters,2/45,0.665369764985953,1,0,0,0.8888888888888888,0.3621443158089169,ABCA1;ABCC11
Serotonergic synapse,5/113,0.6723926318192525,1,0,0,0.8849557522123893,0.3512502969378424,GABRB3;ITPR2;GNB3;HTR3D;CYP2C19
Morphine addiction,4/91,0.6732482464251353,1,0,0,0.8791208791208791,0.34781639730574376,GABRB3;PDE3B;GNB3;PDE8B
Other types of O-glycan biosynthesis,1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,POMT1
Type II diabetes mellitus,2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,IKBKB;GCK
Tuberculosis,8/179,0.677184898085746,1,0,0,0.8938547486033519,0.34843435038653225,CD74;IL6;IL23A;IRAK2;EP300;CD14;ATP6V0D2;IFNA10
Renin secretion,3/69,0.6772948191670352,1,0,0,0.8695652173913043,0.338824888725687,PDE3B;ITPR2;ADRB2
Th1 and Th2 cell differentiation,4/92,0.6815826288475257,1,0,0,0.8695652173913043,0.333337208380493,IKBKB;NFKBIA;IL2RB;DLL1
Estrogen signaling pathway,6/137,0.6868931771447399,1,0,0,0.8759124087591241,0.3289721085839843,HSPA8;HSP90AB1;KRT38;ITPR2;KRT20;KRT31
Ubiquitin mediated proteolysis,6/137,0.6868931771447399,1,0,0,0.8759124087591241,0.3289721085839843,PRKN;AIRE;UBE2D2;NHLRC1;PIAS2;RHOBTB2
Histidine metabolism,1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,ALDH3A1
Mannose type O-glycan biosynthesis,1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,POMT1
Protein export,1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,SRPRA
Proximal tubule bicarbonate reclamation,1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,PCK1
Thyroid hormone signaling pathway,5/116,0.6946174064374339,1,0,0,0.8620689655172414,0.3141328270082842,SLCO1C1;EP300;DIO3;SLC16A2;FOXO1
B cell receptor signaling pathway,3/71,0.6959812822212856,1,0,0,0.8450704225352113,0.30628099636865247,IKBKB;NFKBIA;RAC3
Intestinal immune network for IgA production,2/48,0.6997136081858564,1,0,0,0.8333333333333333,0.29757013234898655,IL6;MAP3K14
Fluid shear stress and atherosclerosis,6/139,0.7002204199629493,1,0,0,0.8633093525179856,0.30764901396557814,IKBKB;HSP90AB1;SDC4;GSTA3;GSTA1;RAC3
NF-kappa B signaling pathway,4/95,0.7056844804748206,1,0,0,0.8421052631578947,0.2935469919093557,IKBKB;NFKBIA;CD14;MAP3K14
Cocaine addiction,2/49,0.7104927276749392,1,0,0,0.8163265306122448,0.2790176057147895,GRIA2;GRIN2B
Neurotrophin signaling pathway,5/119,0.7157855087234404,1,0,0,0.8403361344537815,0.2809871644732814,NFKBIA;IKBKB;IRAK2;RPS6KA1;TP73
Sphingolipid signaling pathway,5/119,0.7157855087234404,1,0,0,0.8403361344537815,0.2809871644732814,PPP2R1B;PPP2R2B;PPP2R2D;RAC3;SGMS2
Parkinson disease,6/142,0.7194862015133059,1,0,0,0.8450704225352113,0.2782123358209349,PRKN;NDUFA6;ATP5PB;ATP5MC3;COX6A1;ATP5F1C
N-Glycan biosynthesis,2/50,0.7209459791839935,1,0,0,0.7999999999999999,0.2617528554824198,ALG13;DDOST
alpha-Linolenic acid metabolism,1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,ACOX1
Thermogenesis,10/231,0.72388661555566,1,0,0,0.8658008658008657,0.279758014899848,NDUFA6;ATP5PB;DPF1;RPS6KA1;ATP5MC3;PLIN1;ATP5F1C;COX6A1;COA6;COX20
cGMP-PKG signaling pathway,7/166,0.7296137574922477,1,0,0,0.8433734939759036,0.2658650469053982,KCNU1;PPP1R12A;PDE3B;ITPR2;KCNMB4;ADRB2;PIK3R6
Amyotrophic lateral sclerosis (ALS),2/51,0.7310789651903944,1,0,0,0.7843137254901961,0.24567356984329963,GRIA2;GRIN2B
Progesterone-mediated oocyte maturation,4/99,0.7357196016371502,1,0,0,0.8080808080808081,0.24800501727640314,MOS;HSP90AB1;RPS6KA1;PDE3B
Human immunodeficiency virus 1 infection,9/212,0.738488191297845,1,0,0,0.8490566037735848,0.2573916514442508,DCAF1;IKBKB;NFKBIA;PXN;RAC3;ITPR2;GNB3;AP1M2;IFNA10
cAMP signaling pathway,9/212,0.738488191297845,1,0,0,0.8490566037735848,0.2573916514442508,NFKBIA;GRIA2;PPP1R12A;ACOX1;PDE3B;RAC3;EP300;ADRB2;GRIN2B
Hepatocellular carcinoma,7/168,0.7408637352815205,1,0,0,0.8333333333333333,0.2499488030031976,PBRM1;WNT5B;TERT;GSTA3;DPF1;GSTA1;MET
Antigen processing and presentation,3/77,0.7470972136000291,1,0,0,0.7792207792207791,0.22718958204818146,CD74;HSPA8;HSP90AB1
Cell cycle,5/124,0.7487088303457675,1,0,0,0.8064516129032258,0.23339122223979591,STAG2;PCNA;MCM3;EP300;MCM4
T cell receptor signaling pathway,4/101,0.7498448770134236,1,0,0,0.792079207920792,0.22803083128155077,NFKBIA;IKBKB;LCP2;MAP3K14
Fatty acid elongation,1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,ELOVL4
Autoimmune thyroid disease,2/53,0.7504077852742062,1,0,0,0.7547169811320754,0.21670830680118947,PRF1;IFNA10
Glycosaminoglycan biosynthesis,2/53,0.7504077852742062,1,0,0,0.7547169811320754,0.21670830680118947,EXT2;XYLT1
Retrograde endocannabinoid signaling,6/148,0.7553912967971983,1,0,0,0.8108108108108109,0.22744815412465288,GABRB3;GRIA2;GRM5;NDUFA6;ITPR2;GNB3
Fanconi anemia pathway,2/54,0.7596159436572443,1,0,0,0.7407407407407407,0.2036609709042825,RMI2;FANCG
Human T-cell leukemia virus 1 infection,9/219,0.7718008106095379,1,0,0,0.821917808219178,0.21290036679018165,IKBKB;NFKBIA;IL6;XPO1;TERT;IL2RB;TBPL1;EP300;MAP3K14
Linoleic acid metabolism,1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,CYP2C19
Phagosome,6/152,0.7773915271524404,1,0,0,0.7894736842105262,0.19879828387763243,STX7;CD14;CD36;ATP6V0D2;MBL2;VAMP3
Endocytosis,10/244,0.7830666966457429,1,0,0,0.8196721311475409,0.20044049648990897,GIT2;HSPA8;EHD3;PIP5KL1;IL2RB;ARAP2;SH3GL2;ARFGAP1;CYTH1;SH3GL1
Nicotinate and nicotinamide metabolism,1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,AOX1
beta-Alanine metabolism,1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,ALDH3A1
Lysine degradation,2/59,0.8013529002820844,1,0,0,0.6779661016949152,0.15013820630777816,SETD3;AASS
VEGF signaling pathway,2/59,0.8013529002820844,1,0,0,0.6779661016949152,0.15013820630777816,PXN;RAC3
Viral myocarditis,2/59,0.8013529002820844,1,0,0,0.6779661016949152,0.15013820630777816,PRF1;RAC3
Propanoate metabolism,1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,ACSS1
Wnt signaling pathway,6/158,0.8075497749747111,1,0,0,0.7594936708860759,0.1623422164173327,WNT5B;RSPO2;PRICKLE2;EP300;RAC3;PPARD
Insulin secretion,3/86,0.8106028254070419,1,0,0,0.6976744186046511,0.14649563666446674,KCNU1;KCNMB4;GCK
Fructose and mannose metabolism,1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,PFKFB3
Apelin signaling pathway,5/137,0.8208780761188903,1,0,0,0.72992700729927,0.14407349424250715,PDE3B;ITPR2;GNB3;PLIN1;PIK3R6
Toxoplasmosis,4/113,0.8226434279131911,1,0,0,0.7079646017699115,0.13821765033879096,NFKBIA;IKBKB;HSPA8;PIK3R6
Necroptosis,6/162,0.8258200247560288,1,0,0,0.7407407407407407,0.14176179030125863,HSP90AB1;MLKL;TNFRSF10B;RBCK1;IRF9;IFNA10
Transcriptional misregulation in cancer,7/186,0.8273600898825334,1,0,0,0.7526881720430108,0.1426458959005734,IL6;HPGD;ID2;IL2RB;CD14;MET;FOXO1
Hepatitis B,6/163,0.8301653781445008,1,0,0,0.7361963190184049,0.13702847651248054,NFKBIA;IKBKB;IL6;PCNA;EP300;IFNA10
"Alanine, aspartate and glutamate metabolism",1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,AGXT2
RNA transport,6/165,0.8385956609296656,1,0,0,0.7272727272727272,0.12801935886721602,NXF2;XPO1;EIF1AX;ELAC2;PABPC1;NUP37
Starch and sucrose metabolism,1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,GCK
Central carbon metabolism in cancer,2/65,0.8428493095437481,1,0,0,0.6153846153846154,0.10521051812214251,MET;GCK
Pathways in cancer,22/530,0.844195657459869,1,0,0,0.830188679245283,0.14060987817322404,HSP90AB1;WNT5B;EPO;DLL1;FOXO1;IKBKB;MSH6;NFKBIA;IL6;TERT;IL23A;GSTA3;IL2RB;GSTA1;FGF18;RAC3;EP300;GNB3;MET;PPARD;IFNA10;F2RL3
Aminoacyl-tRNA biosynthesis,2/66,0.8489478345965421,1,0,0,0.6060606060606061,0.09924699267132996,RARS2;TARS2
African trypanosomiasis,1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,IL6
Primary immunodeficiency,1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,AIRE
Adrenergic signaling in cardiomyocytes,5/145,0.8563159481665291,1,0,0,0.689655172413793,0.10697646387244193,PPP2R1B;PPP2R2B;PPP2R2D;ADRB2;PIK3R6
Allograft rejection,1/38,0.8578665401729517,1,0,0,0.5263157894736842,0.08068775746154062,PRF1
Tight junction,6/170,0.8581972449758943,1,0,0,0.7058823529411764,0.10794445882261061,PCNA;PPP2R1B;PPP2R2B;PPP2R2D;MYH11;CRB3
Amphetamine addiction,2/68,0.860502636162266,1,0,0,0.588235294117647,0.08837564694787858,GRIA2;GRIN2B
Fc epsilon RI signaling pathway,2/68,0.860502636162266,1,0,0,0.588235294117647,0.08837564694787858,RAC3;LCP2
Renal cell carcinoma,2/69,0.8659715129706728,1,0,0,0.5797101449275363,0.08342218313842696,EP300;MET
Circadian entrainment,3/97,0.8694002721574682,1,0,0,0.6185567010309279,0.08656802931150201,GRIA2;GNB3;GRIN2B
Gastric cancer,5/149,0.871720550894918,1,0,0,0.6711409395973154,0.09213850710843985,MUC2;WNT5B;TERT;FGF18;MET
Non-alcoholic fatty liver disease (NAFLD),5/149,0.871720550894918,1,0,0,0.6711409395973154,0.09213850710843985,ERN1;IKBKB;IL6;NDUFA6;COX6A1
Oocyte meiosis,4/125,0.8769959948339774,1,0,0,0.64,0.08400182624919345,MOS;PPP2R1B;RPS6KA1;ITPR2
MAPK signaling pathway,11/295,0.8770572182883419,1,0,0,0.7457627118644068,0.09783142378954804,RPS6KA4;IKBKB;HSPA8;PTPRR;ANGPT1;RPS6KA1;FGF18;RAC3;CD14;MAP3K14;MET
Human cytomegalovirus infection,8/225,0.8799612669690521,1,0,0,0.711111111111111,0.09093503095926067,IKBKB;NFKBIA;IL6;PXN;RAC3;ITPR2;GNB3;IFNA10
Epstein-Barr virus infection,7/201,0.8805619416668193,1,0,0,0.6965174129353233,0.08859353598323239,IKBKB;NFKBIA;IL6;ENTPD3;MAP3K14;IRF9;IFNA10
Melanoma,2/72,0.8812175551168138,1,0,0,0.5555555555555555,0.07025041245674381,FGF18;MET
mTOR signaling pathway,5/152,0.8823360987788662,1,0,0,0.6578947368421052,0.08235673104394964,IKBKB;WNT5B;RRAGB;STRADB;RPS6KA1
AGE-RAGE signaling pathway in diabetic complications,3/100,0.8823533306415342,1,0,0,0.6,0.07509762093621879,IL6;AGER;FOXO1
Ribosome biogenesis in eukaryotes,3/101,0.8864097011888528,1,0,0,0.594059405940594,0.07162931796059352,NXF2;XPO1;SNU13
MicroRNAs in cancer,11/299,0.8870897582699648,1,0,0,0.7357859531772576,0.08815385924650772,MIR335;IKBKB;MIR30A;MIR375;CCNG1;MIR141;TNC;EP300;MIR96;MET;MIRLET7B
Type I diabetes mellitus,1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,PRF1
Bacterial invasion of epithelial cells,2/74,0.8904734986911036,1,0,0,0.5405405405405406,0.06270374958254536,PXN;MET
Thyroid hormone synthesis,2/74,0.8904734986911036,1,0,0,0.5405405405405406,0.06270374958254536,IYD;ITPR2
Axon guidance,6/181,0.8944603755722496,1,0,0,0.6629834254143646,0.0739456407948574,WNT5B;FES;RAC3;SEMA3F;MET;ROBO1
Gastric acid secretion,2/75,0.8948461559431564,1,0,0,0.5333333333333333,0.0592551830845253,ITPR2;SLC26A7
Pancreatic cancer,2/75,0.8948461559431564,1,0,0,0.5333333333333333,0.0592551830845253,IKBKB;RAC3
Carbohydrate digestion and absorption,1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,TAS1R2
Chronic myeloid leukemia,2/76,0.8990559259149057,1,0,0,0.5263157894736842,0.056005282852014004,IKBKB;NFKBIA
Proteasome,1/45,0.9008174591944802,1,0,0,0.4444444444444444,0.046423395514619575,PSMB8
Ether lipid metabolism,1/47,0.9105090567783704,1,0,0,0.42553191489361697,0.03989422673431822,PAFAH1B1
Calcium signaling pathway,6/188,0.9131597476168598,1,0,0,0.6382978723404255,0.0579858151181627,GNA14;GRM5;ADORA2B;ITPKA;ITPR2;ADRB2
Regulation of actin cytoskeleton,7/214,0.9149059511108625,1,0,0,0.6542056074766354,0.058181124544326494,MOS;GSN;PPP1R12A;PXN;FGF18;RAC3;ITGAE
Amino sugar and nucleotide sugar metabolism,1/48,0.914994048233663,1,0,0,0.41666666666666663,0.03701571599601437,GCK
Endocrine and other factor-regulated calcium reabsorption,1/48,0.914994048233663,1,0,0,0.41666666666666663,0.03701571599601437,CALB1
Neuroactive ligand-receptor interaction,12/338,0.9189807709672625,1,0,0,0.7100591715976331,0.0599929567180334,GABRB3;GRIA2;GRM5;TAAR8;CNR2;ADORA2B;GRIK3;UTS2;TAC4;ADRB2;GRIN2B;F2RL3
Ovarian steroidogenesis,1/49,0.919254474341766,1,0,0,0.4081632653061224,0.034364200583535946,AKR1C3
Signaling pathways regulating pluripotency of stem cells,4/139,0.9216307962341534,1,0,0,0.5755395683453237,0.04697011427115409,SOX2;WNT5B;ID2;ID1
Vibrio cholerae infection,1/50,0.9233015685863551,1,0,0,0.39999999999999997,0.03191974852547144,ATP6V0D2
Cholinergic synapse,3/112,0.9234195962447295,1,0,0,0.5357142857142857,0.04268118605193645,ITPR2;GNB3;PIK3R6
Mineral absorption,1/51,0.9271460027962314,1,0,0,0.39215686274509803,0.029664402156312095,TF
Colorectal cancer,2/86,0.9333063042418757,1,0,0,0.46511627906976744,0.032103177510297835,MSH6;RAC3
Salmonella infection,2/86,0.9333063042418757,1,0,0,0.46511627906976744,0.032103177510297835,IL6;CD14
Focal adhesion,6/199,0.9367347778999319,1,0,0,0.6030150753768844,0.03941010533489616,RELN;PPP1R12A;PXN;TNC;RAC3;MET
Gap junction,2/88,0.9386840239616273,1,0,0,0.45454545454545453,0.028761981412220677,GRM5;ITPR2
Proteoglycans in cancer,6/201,0.9403516571166085,1,0,0,0.5970149253731343,0.03671723603686233,PPP1R12A;SDC4;WNT5B;PXN;ITPR2;MET
Pathogenic Escherichia coli infection,1/55,0.9406924613791231,1,0,0,0.3636363636363636,0.022232368682920493,CD14
Phospholipase D signaling pathway,4/148,0.9420378113831829,1,0,0,0.5405405405405406,0.032275603102025825,GRM5;AGPAT2;PIK3R6;CYTH1
Ras signaling pathway,7/232,0.9482160577150395,1,0,0,0.603448275862069,0.032087091033292194,IKBKB;ANGPT1;FGF18;RAC3;GNB3;GRIN2B;MET
Small cell lung cancer,2/93,0.9503836736321627,1,0,0,0.43010752688172044,0.021887960833825593,IKBKB;NFKBIA
Cushing syndrome,4/155,0.954421312324339,1,0,0,0.5161290322580645,0.024077459534487835,MRAP;WNT5B;ITPR2;PDE8B
Autophagy,3/128,0.9578577572454201,1,0,0,0.46875,0.02018249573547579,ERN1;IGBP1;RRAGB
Basal cell carcinoma,1/63,0.9607020222041087,1,0,0,0.31746031746031744,0.012727297981234762,WNT5B
Olfactory transduction,15/444,0.9615224510841446,1,0,0,0.6756756756756757,0.02651173254351233,OR7G2;OR2T27;OR2D3;OR6C76;OR13J1;OR11H4;OR1K1;OR10AD1;OR2T5;OR4S1;OR2T4;OR4D6;OR8D1;OR4B1;OR4F21
Choline metabolism in cancer,2/99,0.9616193258375976,1,0,0,0.40404040404040403,0.015812774876077424,CHKB;RAC3
Inflammatory mediator regulation of TRP channels,2/100,0.9632369873558141,1,0,0,0.39999999999999997,0.014982321868347009,PRKCH;ITPR2
Mitophagy,1/65,0.9645452489317999,1,0,0,0.3076923076923077,0.011107241028940524,PRKN
Melanogenesis,2/101,0.9647890418591292,1,0,0,0.396039603960396,0.014196360797659355,WNT5B;EP300
Systemic lupus erythematosus,3/133,0.9652081031256262,1,0,0,0.45112781954887216,0.015975135331615462,C4B;C1QB;GRIN2B
Longevity regulating pathway,2/102,0.9662779974899206,1,0,0,0.39215686274509803,0.013452432976578837,HSPA8;FOXO1
Prolactin signaling pathway,1/70,0.972589533427257,1,0,0,0.2857142857142857,0.007940897858985217,GCK
Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.9752710378445755,1,0,0,0.27777777777777773,0.006955516411879717,PKP2
Leishmaniasis,1/74,0.9776904281936729,1,0,0,0.2702702702702703,0.00609789044447976,NFKBIA
Breast cancer,3/147,0.9798793347088299,1,0,0,0.4081632653061224,0.008296262345513448,WNT5B;FGF18;DLL1
Alcoholism,4/180,0.9813594217944765,1,0,0,0.4444444444444444,0.008362890420356268,ADORA2B;GNB3;HDAC8;GRIN2B
Cardiac muscle contraction,1/78,0.9818427613794292,1,0,0,0.2564102564102564,0.004698488267500739,COX6A1
Synaptic vesicle cycle,1/78,0.9818427613794292,1,0,0,0.2564102564102564,0.004698488267500739,ATP6V0D2
Oxytocin signaling pathway,3/153,0.9841596838760519,1,0,0,0.39215686274509803,0.006261613621206199,PPP1R12A;ITPR2;PIK3R6
Hypertrophic cardiomyopathy (HCM),1/85,0.987338361755133,1,0,0,0.23529411764705882,0.0029982305654579823,IL6
Cellular senescence,3/160,0.988053565127078,1,0,0,0.37499999999999994,0.004506887620583272,IL6;ITPR2;FOXO1
Relaxin signaling pathway,2/130,0.9901920980145356,1,0,0,0.3076923076923077,0.0030327127009217966,NFKBIA;GNB3
Fc gamma R-mediated phagocytosis,1/91,0.9907047643496917,1,0,0,0.21978021978021978,0.002052462844095697,GSN
GnRH signaling pathway,1/93,0.9916148544307698,1,0,0,0.21505376344086022,0.0018108599286685806,ITPR2
Aldosterone synthesis and secretion,1/98,0.9935192823457568,1,0,0,0.2040816326530612,0.0013268997301213528,ITPR2
Pancreatic secretion,1/98,0.9935192823457568,1,0,0,0.2040816326530612,0.0013268997301213528,ITPR2
"Parathyroid hormone synthesis, secretion and action",1/106,0.9957088736018097,1,0,0,0.18867924528301885,8.113886235340445e-4,ITPR2
Leukocyte transendothelial migration,1/112,0.9968503216903181,1,0,0,0.17857142857142855,5.633301761622566e-4,PXN
